2 Small-Cap Biotech Stocks Well Positioned for a Breakout

For decades, savvy investors have been finding stocks that can produce dramatic gains in relatively short timeframes by sifting through the biotechnology universe. In this wonky industry, positive clinical trial results can cause small-cap stocks to double in value in a single trading session.At the moment, aTyr Pharma (NASDAQ: LIFE), and MoonLake Immunotherapeutics (NASDAQ: MLTX) are running clinical trials that could lead to big gains for their stock prices, depending on the results.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool